Edition:
United States

Healthcare Facilities & Services

Page 2

Labgenomics announces patent granted

Thursday, 28 Apr 2016 08:23pm EDT

Labgenomics Co Ltd:Receives a patent on April 28, for method of detecting chromosomal abnormalities.Patent number of 10-2015-0030641.

Labgenomics announces patent granted

Tuesday, 5 Apr 2016 08:38pm EDT

Labgenomics Co Ltd:Receives a patent on April 6, for High Definition Probe for detecting human papilloma virus and kit using the same.Patent number of 2015-0130985.

LifeWatch AG receives FDA clearance for its continuous Vital Signs Monitoring Service​

Tuesday, 9 Feb 2016 01:00am EST

LifeWatch AG:Announces that it has received FDA clearance for its continuous vital signs monitoring service​.

LifeWatch receives FDA clearance for Mobile Cardiac Telemetry 1-Lead Patch

Monday, 18 Jan 2016 01:00am EST

LifeWatch AG:Receives FDA clearance for its Mobile Cardiac Telemetry 1-Lead Patch.

New data from CombiMatrix Corp study support follow-up diagnostic testing to confirm positive results from non-invasive prenatal testing

Friday, 9 Oct 2015 06:00am EDT

CombiMatrix Corp:New data from Combimatrix study support follow-up diagnostic testing to confirm positive results from non-invasive prenatal testing.Overall true positive and false positive rates for nipt versus diagnostic testing were estimated at about 70 pct. and 20 pct., respectively.Says data show significant false positive rates for microdeletions.

Quest Diagnostics Inc receives FDA clearance to add genital swab claim to moderate complexity simplexa HSV 1 & 2 direct molecular test

Thursday, 3 Sep 2015 10:58am EDT

Quest Diagnostics Inc:Focus Diagnostics products business has received FDA 510 clearance to add genital swab claim to simplexa HSV 1 & 2 direct molecular test on the integrated cycler.

Cancer Genetics awarded largest trial in company history

Tuesday, 30 Jun 2015 07:30am EDT

Cancer Genetics Inc:Says will provide comprehensive biomarker and genomic testing for CLL.Says CLL trials expected to contribute up to $6.2 mln in revenue over several years as patients are selected, treated, and monitored.

Psychemedics Corporation adds FDA cleared drugs to testing panels

Tuesday, 2 Jun 2015 09:00am EDT

Psychemedics Corporation:Says addition of 2 new drugs to the company's drug testing panels.Addition of Oxymorphone was made to the synthetic opiate testing panel and D-Amphetamine/Adderall was added as an option to the Amphetamine panel.

LifeWatch AG Mobile Cardiac Telemetry Patch application filed with the US FDA

Wednesday, 13 May 2015 01:00am EDT

LifeWatch AG:Lifewatch Mobile Cardiac Telemetry Patch application filed with the U.S. FDA.

Quest Diagnostics introduces LeukoVantage

Monday, 4 May 2015 12:53pm EDT

Quest Diagnostics Inc:Announced LeukoVantage, an evidence-based genomic test service that aids in the diagnosis, prognosis, monitoring and selection of treatment for myeloid neoplasms, a group of hematologic malignancies that includes.Acute myeloid leukemia (AML), myelodysplastic syndrome (MDS) and myeloproliferative neoplasms (MPNs).

Markets

  • Sectors
  • U.S.
  • Europe
  • Asia

Sector Summary